Ivenix Infusion System is a prominent player in the Health Care industry, revolutionizing patient care with their state-of-the-art medical technology. Founded in 2007 and headquartered in the United States, the company has positioned itself as a leader in addressing infusion-related patient harm. Its flagship product, the Ivenix Infusion System, is the first of its kind, designed from scratch to align with the latest U.S. Food and Drug Administration guidelines for infusion pumps, effectively tackling recurring safety issues.
The Ivenix Infusion System encompasses a comprehensive suite inclusive of a large-volume infusion pump, administration sets, as well as infusion management tools and analytics. This all-encompassing approach not only ensures the seamless delivery of care but also provides healthcare professionals with valuable insights to enhance efficiency.
The company marked a significant milestone with its Corporate Round investment on 04 May 2021, with Smiths Medical coming on board as a key investor. This infusion of capital is poised to further propel Ivenix Infusion System's growth trajectory, cementing its position as an instrumental force in shaping the future of patient care.